Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRAVAT: Neoadjuvant Chemotherapy in Metastatic Vulvar Carcinoma
NCT04161664Phase 2Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Jan 2020
- Primary completion
- Jan 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin in squamous cell carcinoma of the vulva (VSCC), sponsored by Netherlands Cancer Institute. Started Jan 2020; status: recruiting.
02
Drugs
paclitaxelcarboplatin
03
Conditions
squamous cell carcinoma of the vulva (VSCC)
Beyond the preview
Go deeper on NCT04161664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04161664.